Caroline B. Kurtz

No ORCID on file · 2 papers in corpus
2017
Oral Administration of the Gut-Restricted Guanylate Cyclase-C Agonist, Linaclotide, Reduces Endometriosis-Induced Vaginal Hyperalgesia
·doi:10.1016/s0016-5085(17)32480-0
rct 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
The American journal of gastroenterology ·doi:10.1038/ajg.2012.255

OBJECTIVES: Linaclotide is a minimally absorbed guanylate cyclase-C agonist. The objective of this trial was to determine the efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C). METHODS: …